BIOS - BioScrip, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.2900
-0.0200 (-0.87%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.3100
Open2.3100
Bid0.0000 x 1400
Ask0.0000 x 800
Day's Range2.2200 - 2.3500
52 Week Range1.5600 - 4.1400
Volume792,434
Avg. Volume1,205,734
Market Cap294.856M
Beta (3Y Monthly)0.00
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire15 hours ago

    LogistiCare Announces Leadership Transition

    The Providence Service Corporation (“Providence”) (PRSC) and its subsidiary, LogistiCare Solutions, LLC (“LogistiCare”), today announced that effective immediately R. Carter Pate will serve as Interim Chief Executive Officer of LogistiCare.  Mr. Pate will continue his duties as Providence’s Interim CEO and assumes the responsibilities of Jeff Felton, who has resigned as CEO of LogistiCare effective immediately. Mr. Pate will remain as Interim CEO of Providence and LogistiCare until December 31, 2019.  Over the next six months, Mr. Pate will work with Providence’s Board of Directors to conduct a search internally and externally to identify a permanent CEO for the combined business. Carter Pate is the Founder and Chief Executive Officer of Carter Pate, LLC, a consulting firm he founded in 2014.  Since 2017 he has served as the Interim CEO of Providence Service Corporation (PRSC).

  • PR Newswire3 days ago

    URGENT ALERT: Monteverde & Associates PC Launches an Investigation Regarding the Following Merger

    NEW YORK , June 21, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...

  • GlobeNewswire12 days ago

    Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Care Merger

    Dan Greenleaf, President and Chief Executive Officer of BioScrip, will become Special Advisor to the newly combined company’s Board Chairman, Harry Kraemer, and Chief Executive Officer, John Rademacher.   Mr. Greenleaf will provide strategic and operational counsel to ensure a smooth transition, optimize the integration of both companies, and drive long-term growth opportunities.

  • GlobeNewswire15 days ago

    RLH Corporation Announces Changes to Its Board of Directors

    Adds Accomplished Independent Director R. Carter Pate to Board and Audit Committee Announces Retirement of Director, James P. Evans, Chair of the Board’s Nominating and.

  • GlobeNewswirelast month

    BioScrip to Participate in Upcoming Investor Conferences

    Given BioScrip’s pending combination with Option Care, Option Care’s Chief Executive Officer, John Rademacher, and Chief Financial Officer, Mike Shapiro, plan to accompany BioScrip’s senior leadership at these events.  A live webcast of the Jefferies group presentation and copies of the materials presented can be accessed via BioScrip’s Investor Relations website at https://investors.bioscrip.com/ or through the following link: http://wsw.com/webcast/jeff118/bios/.

  • GlobeNewswire2 months ago

    MERGER INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of BioScrip, Inc. – BIOS

    NEWTOWN SQUARE, Pa., May 03, 2019 -- Kaskela Law LLC announces that it is investigating BioScrip, Inc. (“BioScrip” or the “Company”) (Nasdaq: BIOS) on behalf of the Company’s.

  • GlobeNewswire2 months ago

    BioScrip Reports First Quarter 2019 Financial Results

    DENVER, May 02, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire2 months ago

    BioScrip, Inc. Provides Merger Update

    BioScrip, Inc. (BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today provided an update on its proposed merger with Option Care Enterprises, Inc. (“Option Care”). The Company expects to file the preliminary Option Care merger proxy statement the week of April 29, 2019 with the U.S. Securities and Exchange Commission (“SEC”).  After the proxy statement is filed, management from both BioScrip and Option Care plan to conduct joint analyst and investor meetings.  As part of the analyst and investor meetings, the Company will file an investor presentation with the SEC that will include a business and merger update.

  • ACCESSWIRE3 months ago

    Merger Agreement and Earnings Review in this Comprehensive Report on BioScrip

    NEW YORK, NY / ACCESSWIRE / March 18, 2019 / Traders News Source, a leading independent equity researchand corporate access firm focused on small and mid-cap public companies isissuing a comprehensive report on BioScrip Inc. (BIOS), a provider of infusion and home care management solutions, with approximately 2,500 teammates and nearly 80 service locations across the U.S. BioScrip partners with physicians, hospital systems, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. Recently, BioScrip and Option Care jointly announced a definitive merger agreement, which will create the nation's preeminent home infusion company and transform the industry. Option Care's signature Home Infusion Plus services include the clinical management of infusion medicines, nursing support, and care coordination.

  • GlobeNewswire3 months ago

    BioScrip Reports Fourth Quarter and Full Year 2018 Financial Results

    DENVER, March 15, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire3 months ago

    Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge

    DENVER and BANNOCKBURN, Ill., March 15, 2019 (GLOBE NEWSWIRE) --  BioScrip, Inc. (BIOS) (“BioScrip”) and Option Care Enterprises, Inc. (“Option Care”), the nation’s largest independent providers of home and alternate treatment site infusion therapy services, today announced that they have entered into a definitive merger agreement. The combination is expected to create a leading independent provider with the national reach, comprehensive therapy offering and financial capacity to succeed in the attractive and growing home and alternate site infusion services segment of the $100 billion U.S. infusion market.

  • ACCESSWIRE3 months ago

    BioScrip, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 15, 2019 / BioScrip, Inc. (NASDAQ: BIOS ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 15, 2019, 2018 at 9:00 AM ...

  • GlobeNewswire3 months ago

    BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call

    DENVER, March 13, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire4 months ago

    BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call

    DENVER, Feb. 25, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire5 months ago

    Report: Developing Opportunities within Macy's, Leggett & Platt, Tyler Technologies, BioScrip, DXC Technology, and STERIS plc — Future Expectations, Projections Moving into 2019

    NEW YORK, Jan. 22, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • GlobeNewswire6 months ago

    BioScrip to Present at the 37th Annual J.P. Morgan Healthcare Conference

    DENVER, Jan. 03, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • ACCESSWIRE7 months ago

    Biomedical Trends Fuel New Momentum For Healthcare Stocks; Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Alliqua BioMedical, BioScrip, Coremedix

    CORAL GABLES, FL / ACCESSWIRE / November 28, 2018 / Healthcare stocks and biotechnology stocks have rallied during recent quarters. New developments in technology and drug therapies have boosted excitement within the market. Premier Health Group, Inc. (PHGRF) (PHGI) has engaged discussions with Licensed Producers under the Access to Cannabis for Medical Purposes Regulation, other licensed medical cannabis companies and government officials in order to establish a framework for both patient and physician education.

  • GlobeNewswire7 months ago

    BioScrip to Host Analyst and Investor Day

    DENVER, Nov. 26, 2018 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • ACCESSWIRE7 months ago

    4 Healthcare Stocks Seeing New Highs On Monday

    CORAL GABLES, FL / ACCESSWIRE / November 26, 2018 / Healthcare stocks remain popular during the latest bout of selling pressure within the broader markets. The Frost & Sullivan Healthcare and Life Sciences experts are predicting big disruptions, transformationsand innovations in the coming years as the healthcare industry continues to overhaul outmoded business models. "Our interactive workshop is designed to help managers and CEOs understand key issues affecting the healthcare industry globally," noted Sandeep Sinha, Vice President & Head, Healthcare and Life Sciences, Frost & Sullivan.

  • GlobeNewswire7 months ago

    BioScrip to Present at the Bank of America Merrill Lynch 2018 Leveraged Finance Conference

    DENVER, Nov. 20, 2018 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • ACCESSWIRE7 months ago

    4 Healthcare Stocks Turning Toward Tech For New Growth

    CORAL GABLES, FL / ACCESSWIRE / November 16,2018 / There's no denying the progress that the healthcare industry has made. According to analyst firm Market Research Engine, the E-Health Market is expected to exceed more than US$136 Billion by 2024 at a CAGR of 21% in the given forecast period. Bank of America surveyed** 225 fund managers with $641 billion in assets under management, who said the most "crowded trade" is in tech stocks.

  • GlobeNewswire8 months ago

    BioScrip Reports Third Quarter 2018 Financial Results

    DENVER, Nov. 06, 2018 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire8 months ago

    BioScrip Comments on Implementation of Medicare Home Infusion Transition Benefit

    DENVER, Nov. 01, 2018 (GLOBE NEWSWIRE) --  BioScrip, Inc. (BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Centers for Medicare and Medicaid Services (“CMS”) published a final rule yesterday afternoon for the implementation of a transitional benefit payment, beginning January 1, 2019, for Medicare Part B home infusion services (the “Cures Fix”). BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting.